Cargando…
Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study
BACKGROUND: Individuals with schizophrenia are at elevated genetic risks for comorbid cannabis use, and often experience exacerbations of cognitive and psychotic symptoms when exposed to cannabis. These findings have led a number of investigators to examine cannabinoid CB1 receptor (CB1R) alteration...
Autores principales: | Chou, Shinnyi, Fish, Kenneth N, Lewis, David A, Sweet, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120624/ https://www.ncbi.nlm.nih.gov/pubmed/37090672 http://dx.doi.org/10.1101/2023.04.11.536217 |
Ejemplares similares
-
Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex
por: Chou, Shinnyi, et al.
Publicado: (2022) -
Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017) -
Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018) -
Cannabinoid CB1 receptors regulate salivation
por: Andreis, Kelsey, et al.
Publicado: (2022) -
Voltage dependence of the cannabinoid CB1 receptor
por: Goldberger, Esty, et al.
Publicado: (2022)